Literature DB >> 20153412

Cell-specific targeting in the mouse inner ear using nanoparticles conjugated with a neurotrophin-derived peptide ligand: potential tool for drug delivery.

Soumen Roy1, Alex H Johnston, Tracey A Newman, Rudolf Glueckert, Jozsef Dudas, Mario Bitsche, Elisa Corbacella, Gunde Rieger, Alessandro Martini, Anneliese Schrott-Fischer.   

Abstract

Cell specific targeting is an emerging field in nanomedicine. Homing of the multifunctional nanoparticles (MFNPs) is achieved by the conjugation of targeting moieties on the nanoparticle surface. The inner ear is an attractive target for new drug delivery strategies as it is hard to access and hearing loss is a significant worldwide problem. In this work we investigated the utility of a Nerve Growth Factor-derived peptide (hNgf_EE) functionalized nanoparticles (NPs) to target cells of the inner ear. These functionalized NPs were introduced to organotypic explant cultures of the mouse inner ear and to PC-12 rat pheochromocytoma cells. The NPs did not show any signs of toxicity. Specific targeting and higher binding affinity to spiral ganglion neurons, Schwann cells and nerve fibers of the explant cultures were achieved through ligand mediated multivalent binding to tyrosine kinase receptors and to p75 neurotrophin receptors. Unspecific uptake of NPs was investigated using NPs conjugated with scrambled hNgf_EE peptide. Our results indicate a selective cochlear cell targeting by MFNPs, which may be a potential tool for cell specific drug and gene delivery to the inner ear. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20153412     DOI: 10.1016/j.ijpharm.2010.02.003

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  26 in total

1.  Nanoporous peptide particles for encapsulating and releasing neurotrophic factors in an animal model of neurodegeneration.

Authors:  Justin Tan; Yajun Wang; Xiaopei Yip; Fergal Glynn; Robert K Shepherd; Frank Caruso
Journal:  Adv Mater       Date:  2012-05-21       Impact factor: 30.849

Review 2.  Innovative pharmaceutical approaches for the management of inner ear disorders.

Authors:  Umberto M Musazzi; Silvia Franzé; Francesco Cilurzo
Journal:  Drug Deliv Transl Res       Date:  2018-04       Impact factor: 4.617

Review 3.  Toward the Optical Cochlear Implant.

Authors:  Tobias Dombrowski; Vladan Rankovic; Tobias Moser
Journal:  Cold Spring Harb Perspect Med       Date:  2019-08-01       Impact factor: 6.915

Review 4.  Delivery of therapeutics to the inner ear: The challenge of the blood-labyrinth barrier.

Authors:  Sophie Nyberg; N Joan Abbott; Xiaorui Shi; Peter S Steyger; Alain Dabdoub
Journal:  Sci Transl Med       Date:  2019-03-06       Impact factor: 17.956

5.  Polyamidoamine dendrimers as gene delivery carriers in the inner ear: How to improve transfection efficiency.

Authors:  Hui Wang; Hai-Bo Shi; Shan-Kai Yin
Journal:  Exp Ther Med       Date:  2011-06-27       Impact factor: 2.447

Review 6.  Advances in nano-based inner ear delivery systems for the treatment of sensorineural hearing loss.

Authors:  Lilun Li; Tiffany Chao; Jason Brant; Bert O'Malley; Andrew Tsourkas; Daqing Li
Journal:  Adv Drug Deliv Rev       Date:  2016-01-12       Impact factor: 15.470

Review 7.  New molecular therapies for the treatment of hearing loss.

Authors:  Yutian Ma; Andrew K Wise; Robert K Shepherd; Rachael T Richardson
Journal:  Pharmacol Ther       Date:  2019-05-08       Impact factor: 12.310

8.  Nuclear entry of hyperbranched polylysine nanoparticles into cochlear cells.

Authors:  Weikai Zhang; Ya Zhang; Marian Löbler; Klaus-Peter Schmitz; Aqeel Ahmad; Ilmari Pyykkö; Jing Zou
Journal:  Int J Nanomedicine       Date:  2011-03-14

9.  Filling the silent void: genetic therapies for hearing impairment.

Authors:  Joel Sng; Thomas Lufkin
Journal:  Genet Res Int       Date:  2012-12-04

10.  Peptide-mediated targeting of liposomes to TrkB receptor-expressing cells.

Authors:  Sanjeev Ranjan; Rohit Sood; Jozsef Dudas; Rudolf Glueckert; Anneliese Schrott-Fischer; Soumen Roy; Ilmari Pyykkö; Paavo K J Kinnunen
Journal:  Int J Nanomedicine       Date:  2012-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.